Cargando…
Tear proteomics in dry eye disease
Dry eye disease (DED) is a multi-factorial ocular surface condition driven by compromised ocular lubrication and inflammation which leads to itching, dryness, and vision impairment. The available treatment modalities primarily target the acquired symptoms of DED including tear film supplements, anti...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276753/ https://www.ncbi.nlm.nih.gov/pubmed/37026251 http://dx.doi.org/10.4103/IJO.IJO_2851_22 |
_version_ | 1785060144773595136 |
---|---|
author | Kannan, Ramaraj Das, Samayitree Shetty, Rohit Zhou, Lei Ghosh, Arkasubhra Deshpande, Vrushali |
author_facet | Kannan, Ramaraj Das, Samayitree Shetty, Rohit Zhou, Lei Ghosh, Arkasubhra Deshpande, Vrushali |
author_sort | Kannan, Ramaraj |
collection | PubMed |
description | Dry eye disease (DED) is a multi-factorial ocular surface condition driven by compromised ocular lubrication and inflammation which leads to itching, dryness, and vision impairment. The available treatment modalities primarily target the acquired symptoms of DED including tear film supplements, anti-inflammatory drugs, mucin secretagogues, etc., However, the underlying etiology is still an area of active research, especially in regard to the diverse etiology and symptoms. Proteomics is a robust approach that has been playing major role in understanding the causative mechanism and biochemical changes in DED by identifying the changes in protein expression profile in tears. Tears are a complex fluid composed of several biomolecules such as proteins, peptides, lipids, mucins, and metabolites secreted from lacrimal gland, meibomian gland, cornea, and vascular sources. Over the past two decades, tears have emerged as a bona-fide source for biomarker identification in many ocular conditions because of the minimally invasive and simple sample collection procedure. However, the tear proteome can be altered by several factors, which increases the complexity of the approach. The recent advancements in untargeted mass spectrometry-based proteomics could overcome such shortcomings. Also, these technological advancements help to distinguish the DED profiles based on its association with other complications such as Sjogren’s syndrome, rheumatoid arthritis, diabetes, and meibomian gland dysfunction. This review summarizes the important molecular profiles found in proteomics studies to be altered in DED which have added to the understanding of its pathogenesis. |
format | Online Article Text |
id | pubmed-10276753 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-102767532023-06-18 Tear proteomics in dry eye disease Kannan, Ramaraj Das, Samayitree Shetty, Rohit Zhou, Lei Ghosh, Arkasubhra Deshpande, Vrushali Indian J Ophthalmol Review Article - Basic Sciences and Applied Research Dry eye disease (DED) is a multi-factorial ocular surface condition driven by compromised ocular lubrication and inflammation which leads to itching, dryness, and vision impairment. The available treatment modalities primarily target the acquired symptoms of DED including tear film supplements, anti-inflammatory drugs, mucin secretagogues, etc., However, the underlying etiology is still an area of active research, especially in regard to the diverse etiology and symptoms. Proteomics is a robust approach that has been playing major role in understanding the causative mechanism and biochemical changes in DED by identifying the changes in protein expression profile in tears. Tears are a complex fluid composed of several biomolecules such as proteins, peptides, lipids, mucins, and metabolites secreted from lacrimal gland, meibomian gland, cornea, and vascular sources. Over the past two decades, tears have emerged as a bona-fide source for biomarker identification in many ocular conditions because of the minimally invasive and simple sample collection procedure. However, the tear proteome can be altered by several factors, which increases the complexity of the approach. The recent advancements in untargeted mass spectrometry-based proteomics could overcome such shortcomings. Also, these technological advancements help to distinguish the DED profiles based on its association with other complications such as Sjogren’s syndrome, rheumatoid arthritis, diabetes, and meibomian gland dysfunction. This review summarizes the important molecular profiles found in proteomics studies to be altered in DED which have added to the understanding of its pathogenesis. Wolters Kluwer - Medknow 2023-04 2023-04-05 /pmc/articles/PMC10276753/ /pubmed/37026251 http://dx.doi.org/10.4103/IJO.IJO_2851_22 Text en Copyright: © 2023 Indian Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Review Article - Basic Sciences and Applied Research Kannan, Ramaraj Das, Samayitree Shetty, Rohit Zhou, Lei Ghosh, Arkasubhra Deshpande, Vrushali Tear proteomics in dry eye disease |
title | Tear proteomics in dry eye disease |
title_full | Tear proteomics in dry eye disease |
title_fullStr | Tear proteomics in dry eye disease |
title_full_unstemmed | Tear proteomics in dry eye disease |
title_short | Tear proteomics in dry eye disease |
title_sort | tear proteomics in dry eye disease |
topic | Review Article - Basic Sciences and Applied Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276753/ https://www.ncbi.nlm.nih.gov/pubmed/37026251 http://dx.doi.org/10.4103/IJO.IJO_2851_22 |
work_keys_str_mv | AT kannanramaraj tearproteomicsindryeyedisease AT dassamayitree tearproteomicsindryeyedisease AT shettyrohit tearproteomicsindryeyedisease AT zhoulei tearproteomicsindryeyedisease AT ghosharkasubhra tearproteomicsindryeyedisease AT deshpandevrushali tearproteomicsindryeyedisease |